Gabrielle Wheway
Has grant
Lecturer in Genomics
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Cellular mutation modelling of pre-mRNA splicing factors to elucidate their function at the primary cilium and their contribution to human disease
Open Date: 2017-09-01
Close Date: 2019-09-01
Grant: Close
Extending the study of splicing factors at the base of the cilium and their role in RP pathogenesis – are PRPF3, 4, SNRNP200, RP9 and DHX38 cilia proteins?
Open Date: 2016-09-01
Close Date: 2017-09-01
Grant: Close
Functional genomics identification and characterization of novel disease genes, mechanisms and pathways of ciliogenesis
Open Date: 2014-09-30
Close Date: 2017-09-29
Grant: Close
‘Something old, something new: histology vs. molecular-biology in fighting genetic disease’.
Open Date: 2011-11-01
Close Date: 2012-11-01
Grant: Close
A systems biology approach to dissect cilia function and its disruption in human genetic disease
Open Date: 2010-06-01
Close Date: 2015-05-31
Articles (1)
Retinitis pigmentosa (RP) affects around 1 in 4000 individuals and represents approximately 25% of cases of vision loss in adults, through death of retinal rod and cone photoreceptor cells. It remains a largely untreatable disease, and research is needed to identify potential targets for therapy. Mutations in 94 different genes have been identified as causing RP, including AGBL5 which encodes the main deglutamylase that regulates and maintains functional levels of cilia tubulin glutamylation, which is essential to initiate ciliogenesis, maintain cilia stability and motility. In this study we use CRISPR-mutated AGBL5 clonal retinal pigmented epithelial cell lines to characterise the cilia defects and hyperglutamylation in these cells and identify potential targets for treatment. We demonstrate rescue of glutamylation to wild-type levels and restoration of ciliogenesis in AGBL5 mutant cells through exogenous expression of AGBL5 , and independently through both stable genomic mutation and transient siRNA knockdown of TTLL5 , which encodes a tubulin glutamylase. This identifies two potential routes to treatment for patients with RP associated with mutations in AGBL5 which will need to be explored further in retinal organoid models of this disease.
Year:
2025
Collaborators (3)
Reuben Pengelly
Principal Teaching Fellow
University of Southampton
Diana Baralle
University of Southampton
David Wilson
University of Southampton
Make your next move.
Prepare your application
Review drafts before you send them.